stabJGL

stabJGL implements a stability-based penalty parameter selection to jointly reconstruct multiple Gaussian graphical models from high-dimensional omics data by selecting network sparsity and between-network similarity.


Key Features:

  • Stability-Based Penalty Parameter Selection: Integrates model stability with likelihood-based similarity selection for tuning penalty parameters and addresses limitations of AIC-based criteria in high-dimensional settings.
  • Joint Graphical Lasso Enhancement: Builds upon the joint graphical lasso framework to jointly estimate multiple inverse covariance matrices with tuned sparsity and similarity.
  • Improved Performance: Demonstrates superior performance relative to the standard joint graphical lasso and other state-of-the-art methods across various performance metrics in high-dimensional data.

Scientific Applications:

  • Network Modeling in Omics: Infers gene and protein association networks using Gaussian graphical models from the non-zero entries of inverse covariance matrices.
  • Integrative Analysis of Multiple Conditions: Leverages similarities across multiple graphical structures for integrative analyses of complex high-dimensional biological datasets.
  • Proteomic Pan-Cancer Analysis: Has been applied to a pan-cancer proteomic study to facilitate discovery of proteomic insights across cancer types.

Methodology:

Extends the joint graphical lasso by incorporating a stability approach to penalty parameter selection that integrates model stability with likelihood-based similarity selection and infers networks via Gaussian graphical models using non-zero entries of inverse covariance matrices.

Topics

Details

License:
MIT
Cost:
Free of charge
Tool Type:
library
Operating Systems:
Mac, Linux, Windows
Programming Languages:
R
Added:
4/19/2024
Last Updated:
11/24/2024

Operations

Publications

Lingjærde C, Richardson S. StabJGL: a stability approach to sparsity and similarity selection in multiple-network reconstruction. Bioinformatics Advances. 2023;3(1). doi:10.1093/bioadv/vbad185. PMID:38152341. PMCID:PMC10751232.

PMID: 38152341
Funding: - UK Medical Research Council programme: MRC MC UU 00002/10

Links